Ligand Pharmaceuticals IncorporatedLa Jolla, CA United States
Company Description
Ligand Pharmaceuticals seeks to discover disease-curing molecules. The drug development company works with gene transcription technology to address assorted illnesses. Its research and development projects include treatments for thrombocytopenia (low platelet count), osteoporosis, Alzheimer's disease, hepatitis C, cancers, cardiovascular ailments, arthritis, asthma, and diabetes. Ligand Pharmaceuticals conducts many of its programs through partnerships with other drugmakers. The company is focused on expanding its development pipeline through additional partnerships, as well as via acquisitions.
| 11085 N. Torrey Pines Rd., Ste. 300 | Phone: 858-550-7500 | http://www.ligand.com |
| La Jolla, CA 92037 | Fax: 858-550-7506 | |
| United States |
Ligand Pharmaceuticals Incorporated Rankings
| Russell 2000 (June 2011) |
Executives
| 22 executives listed for Ligand Pharmaceuticals Incorporated's La Jolla, CA location. | ||
| Chairman | John Kozarich | |
|---|---|---|
| President, CEO, and Director | John Higgins | |
| VP Finance and CFO | John Sharp | |
Financials
| Company Type | Public - NASDAQ: LGND Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 21 |
More Ligand Pharmaceuticals Incorporated Financials
Social Media Center
Leverage D&B's credit assessment tools to positively impact
your business. Get the scoop on Ligand Pharmaceuticals Incorporated now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
